John T. Hamm, MD | Authors

Molecular Targeting in Cancer Therapy: Can We Fulfill the Promise?

November 16, 2012

Work remains in the development of a clinically useful tumor classification system that includes molecular characterization of tumors, in our understanding of the implications of tumor heterogeneity, and in the development of more relevant and efficient clinical trials. Nonetheless, there is great excitement that a new era in the treatment of cancer is beginning.